Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity

SIMPLE SUMMARY: Due to the nonspecific nature of disease symptoms and late diagnosis, prognosis for ovarian cancer remains poor, while its incidence is increasing dramatically. Current treatment options lead to recurrence for over 80% of patients, and there is a real and urgent need to identify new...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeanne, Albin, Sarazin, Thomas, Charlé, Magalie, Moali, Catherine, Fichel, Caroline, Boulagnon-Rombi, Camille, Callewaert, Maïté, Andry, Marie-Christine, Diesis, Eric, Delolme, Frédéric, Rioult, Damien, Dedieu, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508526/
https://www.ncbi.nlm.nih.gov/pubmed/34638503
http://dx.doi.org/10.3390/cancers13195019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508526/
https://www.ncbi.nlm.nih.gov/pubmed/34638503
http://dx.doi.org/10.3390/cancers13195019

Ejemplares similares